Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.86 GBX | +1.18% | +56.36% | -25.22% |
Apr. 22 | EARNINGS AND TRADING: Zenova's Kitemark award; Carnival's eyes savings | AN |
Apr. 18 | Aptamer inks new Optimer+ transplant rejection therapy partnership | AN |
Business Summary
Number of employees: 37
Sales per Business
GBP in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Biotechnology
100.0
%
| 4 | 100.0 % | 2 | 100.0 % | -56.59% |
Sales per region
GBP in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Rest of the World
68.0
%
| - | - | 1 | 68.0 % | - |
United Kingdom
24.4
%
| 1 | 14.8 % | 0 | 24.4 % | -28.48% |
Europe
7.6
%
| 0 | 8.1 % | 0 | 7.6 % | -58.77% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
David Bunka
FOU | Founder | - | 07-12-31 |
Arron Tolley
FOU | Founder | 46 | 07-12-31 |
Andrew Rapson
DFI | Director of Finance/CFO | - | 21-12-31 |
Alastair Fleming
COO | Chief Operating Officer | - | - |
Ilknur Dereli
PRN | Corporate Officer/Principal | - | 21-06-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Dean Fielding
BRD | Director/Board Member | 59 | 23-08-20 |
Arron Tolley
FOU | Founder | 46 | 07-12-31 |
David Bunka
FOU | Founder | - | 07-12-31 |
Steve Hull
CHM | Chairman | 70 | - |
Adam Hargreaves
BRD | Director/Board Member | 46 | 23-08-20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 467,343,673 | 318,076,967 ( 68.06 %) | 0 | 68.06 % |
Company contact information
Sector
Sales per region
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-25.22% | 4.96M | |
+3.41% | 32.18B | |
+14.14% | 7.33B | |
+23.82% | 3.83B | |
-14.26% | 3.23B | |
-27.90% | 1.25B | |
-34.43% | 1.12B | |
+2.01% | 912M | |
-24.21% | 856M | |
-38.47% | 859M |
- Stock Market
- Equities
- APTA Stock
- Company Aptamer Group plc